Funding
Guy Miller
- 2005 NIH Rapid Access to Intervention Development
Redox Encrypted Therapeutics for the Treatment of FRDA
Award: Therapeutic Development Services Agreement - 2005 Friedreich’s Ataxia Research Alliance
Clinical Development of EPI-A0001 for Treatment of FRDA
Amount: $3M - 2005 Muscular Dystrophy Association
Pre-Clinical Development of EPI-A0001 for Treatment of FRDA
Amount: $100K - 2005 Friedreich’s Ataxia Research Alliance
Pre-Clinical Development of EPI-A0001 for Treatment of FRDA
Amount: $300K - 2005 United States Department of Defense- Army
SBIR: Natural Products to Enhance Performance
Amount: $75 K, Phase I SBIR - 2003 Singapore Economic Development Board
RISC Grant: Redox Encrypted Therapeutics
Amount: $20M - 2003 United Kingdom
Plant Derived-Natural Products Discovery
Amount: $1M
Sid Hecht
- NIH National Cooperative Natural Products Drug Discovery Grant CA50771, Mechanism-Based Discovery of Novel Antitumor Agents
- NIH Research Grant CA76297, Interaction of Bleomycin with RNA and DNA
- NIH Research Grant CA77284, Synthesis of Bleomycin Group Antibiotics and Analogues
- NIH Research Grant CA77359, Elaboration of Modified Proteins Using Misacylated tRNAs
- NIH Research Grant AI065316, Novel Tools for the Study of HIV-1 RNase H Inhibition

